干细胞
诱导多能干细胞
再生(生物学)
干细胞疗法
旁分泌信号
祖细胞
背景(考古学)
医学
电池类型
成体干细胞
神经科学
生物
内皮干细胞
生物信息学
细胞生物学
内科学
细胞
胚胎干细胞
基因
古生物学
受体
体外
生物化学
遗传学
作者
Parisa Mardanpour,Karim Nayernia,Saeed Khodayari,Hamid Khodayari,Marek Molcanyi,Jürgen Hescheler
摘要
In the recent decades, cardiovascular diseases emerged as the major leading cause of human mortality. However, current clinical approaches still do not encompass a thorough therapeutic solution for improving heart function of the patients who suffered an extensive myocardial injury. Based on this status quo, stem cells could become a novel option, as a natural source of the new myocardium lineage cells, being capable of paracrine factors secretion, protection or even regeneration of the damaged heart muscle. Efficient stem cell-based therapy of the heart should lead to repair or/and replacement of the degenerated tissue with functional myocardial and endothelial cells. Hereon, various types of pluripotent and multipotent stem cells have been already studied in the pre-clinical and clinical settings, demonstrating their cardiomyogenic and regenerative potential. In this context, as a type of male adult stem/ progenitors, spermatogonial stem cells feature a remarkable ability for a formation of cardiovascular lineages, based on our own observations. Presented data supports the presumption, that spermatogonial stem cells not only have a suitable capacity to generate functional heart cells but can also potentially improve the function of an injured myocardium. In this review article, we first describe the essential molecular and pathophysiological mechanisms involved in the heart tissue injury. Afterwards, based on our ongoing study, we review the impact of the stem cell technologies on the regeneration therapy in cardiovascular and myocardial diseases. Particular emphasis is being put on the usability of spermatogonial stem cells in cardiac therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI